solu - celestan - 4 mg/ml injektionslösung
organon healthcare gmbh - betamethason dinatriumphosphat - betamethason
betamethasone dipropionate cream
glenmark pharmaceuticals inc., usa - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - risk summary there are no data regarding the excretion of betamethasone dipropionate in breast milk, the effects on the breastfed infant, or the effects on milk production after topical application of betamethasone dipropionate cream (augmented) to women who are breastfeeding. it is possible that topical administration of large amounts of betamethasone dipropionate could result in sufficient systemic absorption to produce detectable quantities in human milk. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for betamethasone dipropionate cream (augmented) and any potential adverse effects on the breastfed infant from betamethasone dipropionate cream (augmented) or from the underlying maternal condition. clinical considerations to minimize potential exposure to the breastfed infant via breast milk, use betamethasone dipropionate cream (augmented) on the smallest area of skin and for the shortest duration possible while breastfeeding. advise breastfeeding women not to apply betamethasone dipropionate cream (augmented) directly to the nipple and areola to avoid direct infant exposure [see use in specific populations ( error! hyperlink reference not valid. )] .
betamethasone dipropionate cream
preferred pharmaceuticals, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - risk summary there are no data regarding the excretion of betamethasone dipropionate in breast milk, the effects on the breastfed infant, or the effects on milk production after topical application of betamethasone dipropionate cream (augmented) to women who are breastfeeding. it is possible that topical administration of large amounts of betamethasone dipropionate could result in sufficient systemic absorption to produce detectable quantities in human milk. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for betamethasone dipropionate cream (augmented) and any potential adverse effects on the breastfed infant from betamethasone dipropionate cream (augmented) or from the underlying maternal condition. clinical considerations to minimize potential exposure to the breastfed infant via breast milk, use betamethasone dipropionate cream (augmented) on the smallest area of skin and for the shortest duration possible while breastfeeding. advise breast
diprophos 5 mg/ml - 2 mg/ml injektionssuspension
organon belgium - betamethasone dipropionate; betamethason natrium-phosphat - injektionssuspension - 5 mg/ml - 2 mg/ml - betamethasone dipropionate 6.43 mg/ml; betamethason natrium-phosphat 2.63 mg/ml - betamethasone
diprophos 10 mg/2 ml - 4 mg/2 ml injektionssuspension
organon belgium - betamethasone dipropionate; betamethason natrium-phosphat - injektionssuspension - 10 mg/2 ml - 4 mg/2 ml - betamethasone dipropionate 6.43 mg/ml; betamethason natrium-phosphat 2.63 mg/ml - betamethasone
calcipotriol/betamethasone sandoz 50 microgrammes/0,5 mg/g, pommade
sandoz - calcipotriol 50 microgrammes sous forme de : calcipotriol monohydraté; bétaméthasone 0 - pommade - 50 microgrammes - pour 1 g de pommade > calcipotriol 50 microgrammes sous forme de : calcipotriol monohydraté > bétaméthasone 0,500 mg sous forme de : dipropionate de bétaméthasone - anti-psoriasiques. autres anti-psoriasiques pour usage topique - classe pharmacothérapeutique : anti-psoriasiques. autres anti-psoriasiques pour usage topique, calcipotriol, associations, code atc : d05ax52calcipotriol/betamethasone sandoz pommade est utilisée sur la peau pour traiter le psoriasis en plaques (psoriasis vulgaire) chez les adultes. le psoriasis est dû à une production trop rapide des cellules de votre peau. ceci entraîne rougeur, desquamation et épaississement de la peau.calcipotriol/betamethasone sandoz pommade contient du calcipotriol et de la bétaméthasone.le calcipotriol aide à ramener la vitesse de croissance des cellules de la peau à la normale et la bétaméthasone agit en réduisant l'inflammation.
betamethason xiromed 1 mg/g, oplossing voor cutaan gebruik
medical valley invest ab brädgardsvägen 28 23632 hÖllviken (zweden) - betamethasonvaleraat 1,22 mg/g - oplossing voor cutaan gebruik - carbomeer 980 ; isopropylalcohol ; natriumhydroxide (e 524) ; water, gezuiverd, - betamethasone
betamethason 1 mg/g emulsie voor cutaan gebruik, huidemulsie
sandoz b.v. - betamethasonvaleraat; - emulsie voor cutaan gebruik - betamethasone
betamethason sandoz créme 1 mg/g, hydrofiele crème
sandoz b.v. - betamethasonvaleraat; - crème - betamethasone
betamethason sandoz lotion 1 mg/g, vloeistof voor cutaan gebruik
sandoz b.v. - betamethasonvaleraat; - vloeistof voor cutaan gebruik - betamethasone